These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 366049)

  • 1. Complement-fixing anti--double-stranded DNA with the Crithidia method: a better indicator of active SLE than anti-DNA with the Farr method.
    Huber O; Greenberg ML; Huber J
    J Lab Clin Med; 1979 Jan; 93(1):32-9. PubMed ID: 366049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
    Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S
    Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
    Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
    J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
    Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus.
    Ballou SP; Kushner I
    Clin Exp Immunol; 1979 Jul; 37(1):58-67. PubMed ID: 385188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal.
    Esparza RH; Swaak T; Aarden L; Smeenk R
    J Rheumatol; 1985 Dec; 12(6):1109-17. PubMed ID: 3912506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
    Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
    Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
    Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus.
    Launay D; Schmidt J; Lepers S; Mirault T; Lambert M; Kyndt X; Reumaux D; Duhamel A; Hachulla E; Hatron PY; Prin L; Dubucquoi S
    Clin Chim Acta; 2010 Jul; 411(13-14):959-64. PubMed ID: 20303931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
    Kim KH; Han JY; Kim JM; Lee SW; Chung WT
    Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
    Whitehouse IJ; Fehr K; Wagenhäuser FJ
    Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method.
    Beaulieu A; Quismorio FP; kitridou RC; Friou GJ
    J Rheumatol; 1979; 6(4):389-96. PubMed ID: 392093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.
    Neogi T; Gladman DD; Ibanez D; Urowitz M
    J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of antibodies to double-stranded DNA in 30 systemic lupus erythematosus patients.
    Golan DT; Gilhar A; Wolf V
    Isr J Med Sci; 1979 Jun; 15(6):507-11. PubMed ID: 313389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].
    Pena Sagredo JL; Orte Martinez FJ; Sanchez Andrada S; Sampedro Alvarez J; Novo Fernandez MJ; Rodriguez Valverde V
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):345-50. PubMed ID: 7048503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.